01 1Novugen
01 1ALBENDAZOLE USP
01 1U.A.E
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-24
Pay. Date : 2017-10-10
DMF Number : 32013
Submission : 2017-10-12
Status : Active
Type : II
20
Novugen Pharma Malaysia Sdn Bhd, based in U.A.E, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ALBENDAZOLE USP, with a corresponding US DMF Number 32013.
Remarkably, this DMF maintains an Active status since its submission on October 12, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2018, and payment made on October 10, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
